Delivery Order SPE2DB20D2104-SPE2DB23FR75T

Award Date 1/11/23
Potential Completion Date 1/12/23
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,892.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This is a firm-fixed-price delivery order contract with a completion date of July 2, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,458.22 Firm Fixed Price Delivery Order is for the supply of Mounjaro 5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a completion date of November 22, 2024 and was awarded on November 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.54 Firm Fixed Price Delivery Order is for the supply of Mounjaro 7.5 mg/0.5 ml pens, a pharmaceutical product used in the treatment of conditions such as diabetes. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,779.03 delivery order contract is for the supply of Mounjaro 2.5 mg/0.5 mL pens, a medication used to treat diabetes. The contract has a firm fixed-price pricing type and an ultimate completion date of April 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,132.10 delivery order contract is for the supply of the drug Mounjaro 5 mg/0.5 ml pen, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of November 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mounjaro 12.5 mg/0.5 ml pens. The $2,034.92 firm fixed-price delivery order is for products to be delivered by May 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $3,156.00, for the supply of Mounjaro 10 mg/0.5 ml pens. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,448.81 firm fixed-price delivery order is for the supply of MOUNJARO 7.5 mg/0.5 ml pens, a diabetes medication. The award, which has an ultimate completion date of November 21, 2024, is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mounjaro 5 mg/0.5 ml pens. The contract has a ceiling value of $15,614.67 and a completion date of July 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for $1,557.28 and covers the provision of Mounjaro 15 mg/0.5 ml pens. The contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FR75T
    Delivery Order

This federal contract award, with a ceiling value of $1,263.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 12.5 mg/0.5 ml pens, a medication used for the treatment of diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of January 12, 2023.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:45 AM